Cardiology

Towards the 'holy grail' of anticoagulant drugs

A new spin-out company from the University of Cambridge and Addenbrooke's Hospital, XO1 Ltd, has raised $11 million in funding to develop a new anticoagulant drug which has the potential to save millions of lives by preventing ...

Medications

Supermaterial gives rejected drugs a new chance

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Now Uppsala University researchers show that the new material Upsalite, ...

Vaccination

Cigarette maker BAT announces US vaccine trial launch

British cigarette maker BAT said Wednesday that its US biotech division Kentucky BioProcessing will launch trials of a potential coronavirus vaccine, developed using tobacco plant technology.

Medications

Mapping mechanisms to medications

By charting shifts in gene expression, researchers can gain deeper insights into drug mechanisms and side effects.

Other

Royalty Pharma lets Elan takeover bid expire

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

Other

Judge halts Royalty Pharma's bid for Elan stock

Irish drugmaker Elan Corp.'s fight against a takeover bid by Royalty Pharma has spilled into U.S. federal court, where a judge has issued a temporary restraining order preventing Royalty from completing its offer to buy the ...

page 17 from 20